Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank93
3Y CAGR+6.4%
5Y CAGR+13.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.4%/yr
vs +15.0%/yr prior
5Y CAGR
+13.1%/yr
Recent deceleration
Acceleration
-8.6pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $491.27M | -18.7% |
| 2024 | $603.91M | +50.0% |
| 2023 | $402.63M | -1.2% |
| 2022 | $407.50M | +30.9% |
| 2021 | $311.35M | +17.1% |
| 2020 | $265.97M | -12.5% |
| 2019 | $303.83M | +30.4% |
| 2018 | $232.95M | +6.5% |
| 2017 | $218.78M | +10.3% |
| 2016 | $198.29M | - |